Shrinking brain tumours and opening the door for targeted cancer therapies
A new drug, known as IP1867B, could be used for future treatments of brain tumours.…
Browsing: Head and Neck Cancers
Over half of head and neck cancer patients not prepared for impact on quality of life following treatment
Results from a patient survey exploring the long-term burden of treatment on head and neck…
New gene found for a deadly childhood cancer offers possibility of targeted drug therapy
Neuroblastoma accounts for 15 percent of total childhood cancer deaths. The survival rate of high-risk…
Biomaterial-delivered chemotherapy leads to long-term survival in brain cancer
A combination of chemotherapy drugs during brain cancer surgery using a biodegradable paste, leads to…
Antibodies against HPV16 can develop up to 40 years before throat cancer is diagnosed
An international group of researchers has found that antibodies to the human papilloma virus type…
ASCO 2019: Cleveland researchers test novel gene therapy for glioblastoma
A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and the Case…
ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer
Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people…
Q&A: treating vocal cord cancer
DEAR MAYO CLINIC: My brother was diagnosed with stage 0 squamous cell carcinoma in situ…
Novel nanoparticle enhances radiation tumour killing
Radiation kills tumours by creating oxygen free radicals that damage the tumour DNA. However, the…
The unanticipated early origins of childhood brain cancer
Brain tumours are the leading cause of non-accidental death in children in Canada, but little…